Indivior Pharmaceuticals, Inc. (INDV) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$98.00M | +70.9% |
| 2024 | -$337.00M | -83.2% |
| 2023 | -$184.00M | -1126.7% |
| 2022 | -$15.00M | -112.4% |
| 2021 | $121.00M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$98.00M | +70.9% |
| 2024 | -$337.00M | -83.2% |
| 2023 | -$184.00M | -1126.7% |
| 2022 | -$15.00M | -112.4% |
| 2021 | $121.00M | — |